Logo image of MTX

MINERALS TECHNOLOGIES INC (MTX) Stock Fundamental Analysis

NYSE:MTX - US6031581068 - Common Stock

63.95 USD
-0.16 (-0.25%)
Last: 9/8/2025, 12:17:28 PM
Fundamental Rating

4

MTX gets a fundamental rating of 4 out of 10. The analysis compared the fundamentals against 83 industry peers in the Chemicals industry. MTX has only an average score on both its financial health and profitability. MTX has a valuation in line with the averages, but on the other hand it scores bad on growth.


Dividend Valuation Growth Profitability Health

5

1. Profitability

1.1 Basic Checks

MTX had positive earnings in the past year.
MTX had a positive operating cash flow in the past year.
Each year in the past 5 years MTX has been profitable.
Each year in the past 5 years MTX had a positive operating cash flow.
MTX Yearly Net Income VS EBIT VS OCF VS FCFMTX Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100M 200M

1.2 Ratios

With a Return On Assets value of 0.06%, MTX perfoms like the industry average, outperforming 49.40% of the companies in the same industry.
MTX has a Return On Equity (0.13%) which is comparable to the rest of the industry.
The Return On Invested Capital of MTX (2.13%) is worse than 65.06% of its industry peers.
Measured over the past 3 years, the Average Return On Invested Capital for MTX is in line with the industry average of 6.34%.
The 3 year average ROIC (6.89%) for MTX is well above the current ROIC(2.13%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 0.06%
ROE 0.13%
ROIC 2.13%
ROA(3y)3.68%
ROA(5y)3.88%
ROE(3y)7.46%
ROE(5y)8.15%
ROIC(3y)6.89%
ROIC(5y)6.42%
MTX Yearly ROA, ROE, ROICMTX Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15

1.3 Margins

Looking at the Profit Margin, with a value of 0.10%, MTX is in line with its industry, outperforming 49.40% of the companies in the same industry.
MTX's Profit Margin has been stable in the last couple of years.
The Operating Margin of MTX (3.91%) is worse than 66.27% of its industry peers.
MTX's Operating Margin has been stable in the last couple of years.
The Gross Margin of MTX (25.41%) is comparable to the rest of the industry.
In the last couple of years the Gross Margin of MTX has remained more or less at the same level.
Industry RankSector Rank
OM 3.91%
PM (TTM) 0.1%
GM 25.41%
OM growth 3Y1.32%
OM growth 5Y0.73%
PM growth 3Y-3.75%
PM growth 5Y1.26%
GM growth 3Y2.47%
GM growth 5Y1%
MTX Yearly Profit, Operating, Gross MarginsMTX Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 5 10 15 20 25

5

2. Health

2.1 Basic Checks

MTX has a Return on Invested Capital (ROIC), which is below the Cost of Capital (WACC), which means it is destroying value.
MTX has less shares outstanding than it did 1 year ago.
Compared to 5 years ago, MTX has less shares outstanding
Compared to 1 year ago, MTX has an improved debt to assets ratio.
MTX Yearly Shares OutstandingMTX Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
MTX Yearly Total Debt VS Total AssetsMTX Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 1B 2B 3B

2.2 Solvency

An Altman-Z score of 2.52 indicates that MTX is not a great score, but indicates only limited risk for bankruptcy at the moment.
The Altman-Z score of MTX (2.52) is better than 72.29% of its industry peers.
The Debt to FCF ratio of MTX is 11.09, which is on the high side as it means it would take MTX, 11.09 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 11.09, MTX is doing good in the industry, outperforming 61.45% of the companies in the same industry.
A Debt/Equity ratio of 0.59 indicates that MTX is somewhat dependend on debt financing.
MTX's Debt to Equity ratio of 0.59 is fine compared to the rest of the industry. MTX outperforms 63.86% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 11.09
Altman-Z 2.52
ROIC/WACC0.24
WACC8.93%
MTX Yearly LT Debt VS Equity VS FCFMTX Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

MTX has a Current Ratio of 1.95. This is a normal value and indicates that MTX is financially healthy and should not expect problems in meeting its short term obligations.
MTX has a Current ratio of 1.95. This is comparable to the rest of the industry: MTX outperforms 46.99% of its industry peers.
MTX has a Quick Ratio of 1.35. This is a normal value and indicates that MTX is financially healthy and should not expect problems in meeting its short term obligations.
The Quick ratio of MTX (1.35) is comparable to the rest of the industry.
Industry RankSector Rank
Current Ratio 1.95
Quick Ratio 1.35
MTX Yearly Current Assets VS Current LiabilitesMTX Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2

3. Growth

3.1 Past

The earnings per share for MTX have decreased by -3.55% in the last year.
MTX shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 7.77% yearly.
The Revenue has decreased by -3.93% in the past year.
MTX shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 3.42% yearly.
EPS 1Y (TTM)-3.55%
EPS 3Y7.07%
EPS 5Y7.77%
EPS Q2Q%-6.06%
Revenue 1Y (TTM)-3.93%
Revenue growth 3Y4.47%
Revenue growth 5Y3.42%
Sales Q2Q%-2.27%

3.2 Future

MTX is expected to show a small growth in Earnings Per Share. In the coming years, the EPS will grow by 2.33% yearly.
Based on estimates for the next years, MTX will show a small growth in Revenue. The Revenue will grow by 1.09% on average per year.
EPS Next Y-9.51%
EPS Next 2Y2.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-2.24%
Revenue Next 2Y1.09%
Revenue Next 3YN/A
Revenue Next 5YN/A

3.3 Evolution

The EPS growth rate is decreasing: in the next years the growth will be less than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
MTX Yearly Revenue VS EstimatesMTX Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 500M 1B 1.5B 2B
MTX Yearly EPS VS EstimatesMTX Yearly EPS VS EstimatesYearly EPS VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2 4 6

6

4. Valuation

4.1 Price/Earnings Ratio

With a Price/Earnings ratio of 11.22, the valuation of MTX can be described as very reasonable.
MTX's Price/Earnings ratio is rather cheap when compared to the industry. MTX is cheaper than 83.13% of the companies in the same industry.
MTX is valuated cheaply when we compare the Price/Earnings ratio to 27.02, which is the current average of the S&P500 Index.
With a Price/Forward Earnings ratio of 9.93, the valuation of MTX can be described as very reasonable.
MTX's Price/Forward Earnings ratio is rather cheap when compared to the industry. MTX is cheaper than 86.75% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.66, MTX is valued rather cheaply.
Industry RankSector Rank
PE 11.22
Fwd PE 9.93
MTX Price Earnings VS Forward Price EarningsMTX Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 10 20 30

4.2 Price Multiples

The rest of the industry has a similar Enterprise Value to EBITDA ratio as MTX.
66.27% of the companies in the same industry are more expensive than MTX, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 22.62
EV/EBITDA 15.25
MTX Per share dataMTX EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

PEG (NY)N/A
PEG (5Y)1.44
EPS Next 2Y2.33%
EPS Next 3YN/A

3

5. Dividend

5.1 Amount

MTX has a yearly dividend return of 0.70%, which is pretty low.
MTX's Dividend Yield is slightly below the industry average, which is at 3.49.
With a Dividend Yield of 0.70, MTX pays less dividend than the S&P500 average, which is at 2.45.
Industry RankSector Rank
Dividend Yield 0.7%

5.2 History

The dividend of MTX is nicely growing with an annual growth rate of 15.37%!
MTX has been paying a dividend for at least 10 years, so it has a reliable track record.
MTX has not decreased its dividend for at least 10 years, so it has a reliable track record of non decreasing dividend.
Dividend Growth(5Y)15.37%
Div Incr Years2
Div Non Decr Years31
MTX Yearly Dividends per shareMTX Yearly Dividends per shareYearly Dividends per share 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 0.1 0.2 0.3 0.4

5.3 Sustainability

652.38% of the earnings are spent on dividend by MTX. This is not a sustainable payout ratio.
The dividend of MTX is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP652.38%
EPS Next 2Y2.33%
EPS Next 3YN/A
MTX Yearly Income VS Free CF VS DividendMTX Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 50M 100M 150M
MTX Dividend Payout.MTX Dividend Payout, showing the Payout Ratio.MTX Dividend Payout.PayoutRetained Earnings

MINERALS TECHNOLOGIES INC

NYSE:MTX (9/8/2025, 12:17:28 PM)

63.95

-0.16 (-0.25%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryChemicals
Earnings (Last)07-24 2025-07-24/amc
Earnings (Next)10-22 2025-10-22/amc
Inst Owners100.99%
Inst Owner Change1.59%
Ins Owners1.16%
Ins Owner Change0.37%
Market Cap2.01B
Analysts80
Price Target85.68 (33.98%)
Short Float %1.73%
Short Ratio2.02
Dividend
Industry RankSector Rank
Dividend Yield 0.7%
Yearly Dividend0.41
Dividend Growth(5Y)15.37%
DP652.38%
Div Incr Years2
Div Non Decr Years31
Ex-Date08-15 2025-08-15 (0.11)
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)2.17%
Min EPS beat(2)-4.75%
Max EPS beat(2)9.1%
EPS beat(4)2
Avg EPS beat(4)2.67%
Min EPS beat(4)-4.75%
Max EPS beat(4)9.1%
EPS beat(8)6
Avg EPS beat(8)5.18%
EPS beat(12)8
Avg EPS beat(12)0.33%
EPS beat(16)12
Avg EPS beat(16)1.19%
Revenue beat(2)0
Avg Revenue beat(2)-1.11%
Min Revenue beat(2)-1.18%
Max Revenue beat(2)-1.03%
Revenue beat(4)0
Avg Revenue beat(4)-1.81%
Min Revenue beat(4)-3.09%
Max Revenue beat(4)-1.03%
Revenue beat(8)1
Avg Revenue beat(8)-1.64%
Revenue beat(12)3
Avg Revenue beat(12)-1.38%
Revenue beat(16)5
Avg Revenue beat(16)-1.13%
PT rev (1m)3.28%
PT rev (3m)3.38%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-17.3%
EPS NY rev (1m)-1.67%
EPS NY rev (3m)-4.42%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-5.57%
Revenue NY rev (1m)0.05%
Revenue NY rev (3m)-0.99%
Valuation
Industry RankSector Rank
PE 11.22
Fwd PE 9.93
P/S 0.97
P/FCF 22.62
P/OCF 10.62
P/B 1.21
P/tB 3.83
EV/EBITDA 15.25
EPS(TTM)5.7
EY8.91%
EPS(NY)6.44
Fwd EY10.07%
FCF(TTM)2.83
FCFY4.42%
OCF(TTM)6.02
OCFY9.41%
SpS65.76
BVpS52.71
TBVpS16.69
PEG (NY)N/A
PEG (5Y)1.44
Profitability
Industry RankSector Rank
ROA 0.06%
ROE 0.13%
ROCE 2.83%
ROIC 2.13%
ROICexc 2.39%
ROICexgc 4.3%
OM 3.91%
PM (TTM) 0.1%
GM 25.41%
FCFM 4.3%
ROA(3y)3.68%
ROA(5y)3.88%
ROE(3y)7.46%
ROE(5y)8.15%
ROIC(3y)6.89%
ROIC(5y)6.42%
ROICexc(3y)7.67%
ROICexc(5y)7.18%
ROICexgc(3y)13.35%
ROICexgc(5y)12.39%
ROCE(3y)9.31%
ROCE(5y)8.65%
ROICexcg growth 3Y6.72%
ROICexcg growth 5Y4.56%
ROICexc growth 3Y6.7%
ROICexc growth 5Y3.44%
OM growth 3Y1.32%
OM growth 5Y0.73%
PM growth 3Y-3.75%
PM growth 5Y1.26%
GM growth 3Y2.47%
GM growth 5Y1%
F-Score5
Asset Turnover0.6
Health
Industry RankSector Rank
Debt/Equity 0.59
Debt/FCF 11.09
Debt/EBITDA 5.63
Cap/Depr 107.86%
Cap/Sales 4.86%
Interest Coverage 1.38
Cash Conversion 108.88%
Profit Quality 4223.81%
Current Ratio 1.95
Quick Ratio 1.35
Altman-Z 2.52
F-Score5
WACC8.93%
ROIC/WACC0.24
Cap/Depr(3y)93.37%
Cap/Depr(5y)131.49%
Cap/Sales(3y)4.14%
Cap/Sales(5y)6.45%
Profit Quality(3y)91.22%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-3.55%
EPS 3Y7.07%
EPS 5Y7.77%
EPS Q2Q%-6.06%
EPS Next Y-9.51%
EPS Next 2Y2.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-3.93%
Revenue growth 3Y4.47%
Revenue growth 5Y3.42%
Sales Q2Q%-2.27%
Revenue Next Year-2.24%
Revenue Next 2Y1.09%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y-71.04%
EBIT growth 3Y5.84%
EBIT growth 5Y4.17%
EBIT Next Year19.6%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y39.25%
FCF growth 3YN/A
FCF growth 5Y-3.25%
OCF growth 1Y24.52%
OCF growth 3Y0.57%
OCF growth 5Y-0.16%